Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12433432 | 0.79 | MEN1 (0.36) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL13980116 | 0.73 | MEN1 (0.33) | ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL12433419 | 0.71 | MEN1 (0.33) | ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL16955632 | 0.71 | ALDH1A1 (0.38) | ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL4847783 | 0.70 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2AHTT | |
| SCHEMBL9688509 | 0.70 | SCN4A (0.42) | ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL14553800 | 0.68 | MEN1 (0.42) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL17991846 | 0.68 | ALDH1A1 (0.39) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL14553810 | 0.68 | ALDH1A1 (0.39) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL25527063 | 0.68 | MEN1 (0.33) | ALDH1A1MEN1MAPTKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101900-B2 | Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20050187265-A1 | Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | RHEINHEIMER JOACHIM (DE) | 2005-08-25 | — | — | US | disclosed |
| US-6881742-B1 | Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187265-A1 | Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | CBR3, CBR1, CYP1B1 | ALDH1A1 1086/4885MEN1 1839/4885MAPT 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.